Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bowers

Showing results (291-300 of 424) with videos related to

Pageof 43
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer's disease miceDeborah A Ryan, Michael A Mastrangelo, Wade C Narrow, et al.
Glia|July 29, 2008
Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathologyMaya K Desai, Kelly L Sudol, Michelle C Janelsins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Reduced Pathology and Improved Behavioral Performance in Alzheimer's Disease Mice Vaccinated With HSV Amplicons Expressing Amyloid-β and Interleukin-4Maria E Frazer, Jennifer E Hughes, Michael A Mastrangelo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4Maria E Frazer, Jennifer E Hughes, Michael A Mastrangelo, et al.
Health Services Research|November 26, 2015
The Green House Model of Nursing Home Care in Design and ImplementationLauren W Cohen, Sheryl Zimmerman, David Reed, et al.
The American Journal of Pathology|August 11, 2010
Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic targetMaya K Desai, Michael A Mastrangelo, Deborah A Ryan, et al.
The American Journal of Pathology|April 10, 2013
Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologiesSara L Montgomery, Wade C Narrow, Michael A Mastrangelo, et al.
Gene Therapy|October 30, 2009
Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platformS de Silva, M A Mastrangelo, L T Lotta, et al.
Physical Review Letters|October 10, 2006
Theory of laser acceleration of light-ion beams from interaction of ultrahigh-intensity lasers with layered targetsB J Albright, L Yin, B M Hegelich, et al.
Vaccine|September 18, 2007
HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus primeCindy M P Duke, Casey A Maguire, Michael C Keefer, et al.
Pageof 43

Showing results (291-300 of 424) with videos related to

Sort By:
Pageof 43
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer's disease miceDeborah A Ryan, Michael A Mastrangelo, Wade C Narrow, et al.
Glia|July 29, 2008
Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathologyMaya K Desai, Kelly L Sudol, Michelle C Janelsins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Reduced Pathology and Improved Behavioral Performance in Alzheimer's Disease Mice Vaccinated With HSV Amplicons Expressing Amyloid-β and Interleukin-4Maria E Frazer, Jennifer E Hughes, Michael A Mastrangelo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4Maria E Frazer, Jennifer E Hughes, Michael A Mastrangelo, et al.
Health Services Research|November 26, 2015
The Green House Model of Nursing Home Care in Design and ImplementationLauren W Cohen, Sheryl Zimmerman, David Reed, et al.
The American Journal of Pathology|August 11, 2010
Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic targetMaya K Desai, Michael A Mastrangelo, Deborah A Ryan, et al.
The American Journal of Pathology|April 10, 2013
Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologiesSara L Montgomery, Wade C Narrow, Michael A Mastrangelo, et al.
Gene Therapy|October 30, 2009
Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platformS de Silva, M A Mastrangelo, L T Lotta, et al.
Physical Review Letters|October 10, 2006
Theory of laser acceleration of light-ion beams from interaction of ultrahigh-intensity lasers with layered targetsB J Albright, L Yin, B M Hegelich, et al.
Vaccine|September 18, 2007
HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus primeCindy M P Duke, Casey A Maguire, Michael C Keefer, et al.
Pageof 43